Creating new drugs that target a specific pain receptor to reduce side effects
Design and Synthesis of Collybolide Probes for Kappa-Opioid Receptor
This study is working on creating new medications from a natural substance found in mushrooms that could help relieve pain and itching without the harsh side effects of regular opioids, making it a safer option for people who need pain management.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma NIH-funded |
| Lab location | 1 site (Norman, United States) |
| Project ID | NIH-10692908 on NIH RePORTER |
What this research studies
This research focuses on developing new chemical probes derived from collybolide, a natural product from mushrooms, to target the kappa-opioid receptor (KOR). The goal is to create selective KOR agonists that can provide pain relief without the severe side effects associated with traditional opioids like morphine. By understanding the structural requirements for KOR selectivity, the researchers aim to design drugs that are effective in treating pain and reducing itchiness. This innovative approach could lead to safer pain management options for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic pain or conditions that require effective pain management.
Not a fit: Patients who do not experience pain or have conditions unrelated to the kappa-opioid receptor may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new pain relief medications that have fewer side effects than current opioid treatments.
How similar studies have performed: Other research has shown promise in developing selective opioid receptor agonists, suggesting that this approach could yield significant advancements in pain management.
Where this research is happening
Norman, United States
- University of Oklahoma — Norman, United States (Active)
Researchers
- Principal investigator: Sharma, Indrajeet — University of Oklahoma
- Study coordinator: Sharma, Indrajeet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.